Mary L. Trawick

Baylor University, Waco, TX 
"Mary Trawick"
DOI: 10.1021/ja00420a018

Mean distance: (not calculated yet)


Sign in to add mentor
Miklos Bodanszky grad student 1974 Case Western
 (Side chain interactions in synthetic peptides.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ren W, Vairin R, Ward JD, et al. (2023) Structure Guided Design, Synthesis, and Biological Evaluation of Oxetane-Containing Indole Analogues. Bioorganic & Medicinal Chemistry. 92: 117400
Winn BA, Devkota L, Kuch B, et al. (2020) Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia. Journal of Natural Products
Maguire CJ, Carlson GJ, Ford JW, et al. (2019) Synthesis and biological evaluation of structurally diverse α-conformationally restricted chalcones and related analogues. Medchemcomm. 10: 1445-1456
Niu H, Strecker TE, Gerberich JL, et al. (2019) Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization. Journal of Medicinal Chemistry
Maguire CJ, Chen Z, Mocharla VP, et al. (2018) Synthesis of dihydronaphthalene analogues inspired by combretastatin A-4 and their biological evaluation as anticancer agents. Medchemcomm. 9: 1649-1662
Pinney KG, Trawick ML, Mason RP, et al. (2017) Abstract 3203: Targeting tumor hypoxia with prodrug conjugates of potent small-molecule inhibitors of tubulin polymerization Cancer Research. 77: 3203-3203
Herdman CA, Strecker TE, Tanpure RP, et al. (2016) Synthesis and Biological Evaluation of Benzocyclooctene-based and Indene-based Anticancer Agents that Function as Inhibitors of Tubulin Polymerization. Medchemcomm. 7: 2418-2427
Parker EN, Odutola SO, Wang Y, et al. (2016) Synthesis and biological evaluation of a water-soluble phosphate prodrug salt and structural analogues of KGP94, a lead inhibitor of cathepsin L. Bioorganic & Medicinal Chemistry Letters
Winn BA, Shi Z, Carlson GJ, et al. (2016) Bioreductively activatable prodrug conjugates of phenstatin designed to target tumor hypoxia. Bioorganic & Medicinal Chemistry Letters
Devkota L, Lin CM, Strecker TE, et al. (2016) Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents. Bioorganic & Medicinal Chemistry
See more...